Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Results of a phase I/II reirradiation study.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Radiotherapy and Oncology

• Publication date

  2017-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.radonc.2016.08.023PMID 27745912
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A proposal for the stratification of the risk of locoregional failure after surgical resection, perioperative high dose rate brachytherapy, and external beam irradiation: the University of Navarre predictive model.

  2014cited by this paper
• Wound Healing Complications With Intraoperative Brachytherapy for Head and Neck Cancer: A Unique Form of Radiation Injury

  2014cited by this paper
• Intraoperative high‐dose‐rate radiotherapy in the management of locoregionally recurrent head and neck cancer

  2013cited by this paper
• High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer.

  2012cited by this paper
• Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB).

  2011cited by this paper
• Postoperative reirradiation for mucosal head and neck squamous cell carcinomas.

  2009cited by this paper
• Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.

  2008cited by this paper
• Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.

  2008cited by this paper
• Intraoperative radiation therapy for recurrent head-and-neck cancer: the UCSF experience.

  2007cited by this paper
• The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers

  2007cited by this paper
• High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.

  2007cited by this paper
• Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study.

  2006cited by this paper
• Manually after-loaded 192Ir low-dose rate brachytherapy after subtotal excision and flap reconstruction of recurrent cervical lymphadenopathy from head and neck cancer.

  2006cited by this paper
• Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy

  2006cited by this paper
• Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.

  2004cited by this paper
• The potential uses of high-dose-rate brachytherapy in patients with head and neck cancer

  2004cited by this paper
• Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer

  2003cited by this paper
• The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.

  2003cited by this paper
• Complications following re-irradiation for head and neck cancer.

  2002cited by this paper
• Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma

  2001cited by this paper
• Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.

  2001cited by this paper
• RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck.

  2001cited by this paper
• Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study.

  2000cited by this paper
• Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck.

  1999cited by this paper
• Intraoperative high dose rate brachytherapy can be used to salvage patients with previously irradiated head and neck recurrences.

  1999cited by this paper
• Interstitial high dose rate brachytherapy in locally progressive or recurrent head and neck cancer.

  1999cited by this paper
• Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.

  1998cited by this paper
• Intraoperative electron beam radiotherapy for previously irradiated advanced head and neck malignancies.

  1998cited by this paper
• Simplified non-looping functional loop technique for HDR brachytherapy.

  1998cited by this paper
• IORT in the management of locally advanced or recurrent head and neck cancer.

  1997cited by this paper
• Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease.

  1996cited by this paper
• Salvage treatment for inoperable neck nodes in head and neck cancer using combined iridium‐192 brachytherapy and surgical reconstruction

  1996cited by this paper
• Hyperfractionation in the reirradiation of head and neck cancers. Result of a pilot study

  1995cited by this paper
• Simultaneous interstitial radiotherapy with regional or free-flap reconstruction, following salvage surgery of recurrent head and neck carcinoma. Analysis of complications.

  1994cited by this paper
• High-dose reirradiation of head and neck cancer with curative intent

  1994cited by this paper
• Split course interstitial brachytherapy with a source shift: The results of a new technique for salvage irradiation in recurrent inoperable cervical lymphadenopathy ≥ 4 cm diameter in 23 patients

  1992cited by this paper
• Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation.

  1992cited by this paper
• Intraoperative radiation therapy for recurrent head and neck cancer

  1991cited by this paper
• Iodine-125 seed implantation as an adjunct to surgery in advanced recurrent squamous cell cancer of the head and neck.

  1991cited by this paper
• Reirradiation of recurrent head and neck cancers

  1987cited by this paper
• Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases.

  1987cited by this paper
• Intraoperative radiotherapy in patients with recurrent head and neck cancer.

  1985cited by this paper
• The Effect of Multiple Small Doses of X Rays on Skin Reactions in the Mouse and a Basic Interpretation

  1976cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Salvage brachytherapy for local recurrence of cancer after definitive irradiation: a GEC-ESTRO narrative review.

  2025cites this paper
• Prospective Registry Trial of Adjuvant High‐Dose Rate Brachytherapy in Unirradiated Head and Neck Cancer: 20‐Year Data

  2025cites this paper
• The evolving landscape of head and neck brachytherapy: A scoping review

  2024cites this paper
• Local Control, Survival, and Toxicity Outcomes with High-Dose-Rate Peri-Operative Interventional Radiotherapy (Brachytherapy) in Head and Neck Cancers: A Systematic Review

  2024influential citation
• GEC-ESTRO recommendations for head & neck cancer brachytherapy (interventional radiotherapy): 2nd update with focus on HDR and PDR.

  2024cites this paper
• Pilot Evaluation of Perioperative High Dose Rate Brachytherapy in Head Neck Cancers

  2024influential citation
• Status of head and neck brachytherapy in Spain in 2022

  2023cites this paper
• Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach, part II: radiation technique and fractionations

  2023cites this paper
• Salvage High-Dose-Rate Interventional Radiotherapy (Brachytherapy) Combined with Surgery for Regionally Relapsed Head and Neck Cancers

  2023cites this paper
• Function Preservation in Head and Neck Cancers.

  2023cites this paper
• Repeat re-irradiation with interstitial HDR-brachytherapy for an in-field isolated nodal recurrence in a patient with HPV-positive squamous cell carcinoma of the head and neck.

  2022cites this paper
• Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society® (ARS) Appropriate Use Criteria (AUC): Expert Panel on Radiation Oncology - Head and Neck Cancer.

  2022cites this paper
• Feasibility of accelerated image-guided high-dose-rate interstitial brachytherapy with inverse planning simulated annealing (IPSA-HDRBT) for post-operative treatment of pathologically node-negative squamous cell carcinomas of the oral tongue.

  2022cites this paper
• Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review

  2022cites this paper
• Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer

  2021cites this paper
• American Brachytherapy Society (ABS) consensus statement for soft-tissue sarcoma brachytherapy.

  2021cites this paper
• Perioperative high dose rate brachytherapy in head and neck cancers: case report and review of clinical application

  2021cites this paper
• Permanent Interstitial Cesium-131 Brachytherapy in Treating High-Risk Recurrent Head and Neck Cancer: A Prospective Pilot Study

  2021cites this paper
• Dose Volume Histogram Constraints in Patients with Head and Neck Cancer treated with Surgery and Adjuvant HDR Brachytherapy: A Proposal of the Head and Neck and Skin GEC ESTRO Working Group.

  2020cites this paper
• Head and neck cancer reirradiation with interstitial high‐dose‐rate brachytherapy

  2018cites this paper
• A systematic review of treating recurrent head and neck cancer: a reintroduction of brachytherapy with or without surgery

  2018influential citation
• American Brachytherapy Society consensus statement for soft tissue sarcoma brachytherapy.

  2017cites this paper